Bacos Anthony 4

What Happened Anthony Bacos, Chief Product & Technology Officer at Stitch Fix, exercised stock derivatives and sold shares on July 6, 2026. He exercised 50,000 shares at $2.48 per share (total cost $124,000) and another 50,000 shares reported as a conversion/exercise with $0 cash consideration. Separately, he sold 50,000 shares (weighted avg $3.80; proceeds $189,825) and 20,000 shares (weighted avg $3.76; proceeds $75,264) in open-market transactions, for combined sale proceeds of about $265,089. The sales were executed under a pre-established Rule 10b5-1 trading plan.

Key Details

• Transaction date: July 6, 2026; Form 4 filed July 8, 2026 (appears timely).
• Exercise/acquisition: 50,000 shares at $2.48 = $124,000.
• Conversion/exercise: 50,000 shares @ $0.00 reported (no cash consideration reported).
• Open-market sales: 50,000 shares at weighted avg $3.80 (proceeds $189,825); 20,000 shares at weighted avg $3.76 (proceeds $75,264). Total sale proceeds ≈ $265,089.
• Weighted-price ranges: 50k-sale prices ranged $3.705–$3.845 (footnote F2); 20k-sale prices ranged $3.71–$3.84 (footnote F3). Reporting person can provide breakdowns on request.
• Sale plan: Sales pursuant to a Rule 10b5-1 plan entered March 17, 2026 (footnote F1).
• Vesting note: Option vesting schedule described in filing (footnote F4).
• Shares owned after transaction: Not provided in the data supplied here; see the Form 4 for post-transaction holdings.

Context This filing shows an option/derivative exercise plus immediate open-market sales. The combination of exercising options and selling shares is commonly a routine liquidity action for insiders; the sales here were executed under a 10b5-1 plan, which schedules trades in advance. The Form 4 reports a conversion/exercise with $0 cash consideration for 50,000 shares but does not explain the mechanics — check the full filing for details.